XML 34 R16.htm IDEA: XBRL DOCUMENT v3.24.3
Revenues
 12 Months Ended
Aug. 31, 2024
Revenues  
Revenues 10. Revenues

 

Revenues for the years ended August 31, 2024 and 2023 consist of the following:

 

 

 

Year Ended August 31,

 

 

 

2024

 

 

2023

 

IP Licensing

 

$457,990

 

 

$146,800

 

B2B

 

 

5,388

 

 

 

44,167

 

Other

 

 

900

 

 

 

35,241

 

Total Revenue

 

$464,278

 

 

$226,208

 

Licensing revenue consists of IP licensing fees for transfer of the DehydraTECH technology in line with definitive agreements and includes non-refundable minimum performance fees. The Company recognized $457,990 in licensing revenue during the year. The Company recognized B2B product revenues of $5,388 that relate to sales of our intermediate products for use by B2B customers in their products.